Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro.
Overview
- Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia
- Institute of Molecular Genetics and Genetic Engineering University of Belgrade, Vojvode Stepe 444a, Belgrade, Serbia
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE90604, at NCBI GEO; found in the text, “Data acquisition”
Other data links
- ncbi.nlm.nih.gov/
geo/ , NCBI; found in the text, “Data acquisition”geo2r
Data availability statement
The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- no repository, dataset or request procedure was recognized in it
Read it in the paper: doi.org/10.1038/s41598-026-56920-9.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 8 keywords, 11 MeSH terms, 3 funders, 39 references.
Cite
This paper
Petrović, M., Lapčević, S., Matić, I. Z., Bojić, L., Nikitović, M., Stanojković, T., & Stanisavljević Ninković, D. (2026). Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro. Scientific reports, 16(1), 25942. https://
BibTeX
@article{petrovic2026ove
author = {Petrović, Maja and Lapčević, Simona and Matić, Ivana Z and Bojić, Luka and Nikitović, Marina and Stanojković, Tatjana and Stanisavljević Ninković, Danijela},
title = {{Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro}},
journal = {Scientific reports},
year = {2026},
month = jun,
volume = {16},
number = {1},
pages = {25942},
publisher = {Nature Publishing Group},
issn = {2045-2322},
doi = {10.1038/
url = {https://
pmid = {42252325},
pmcid = {PMC13486710}
}
RIS
TY - JOUR
AU - Petrović, Maja
AU - Lapčević, Simona
AU - Matić, Ivana Z
AU - Bojić, Luka
AU - Nikitović, Marina
AU - Stanojković, Tatjana
AU - Stanisavljević Ninković, Danijela
TI - Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro
T2 - Scientific reports
J2 - Sci Rep
PY - 2026
DA - 2026/
VL - 16
IS - 1
SP - 25942
SN - 2045-2322
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro",
"container-title": "Scientific reports",
"author": [
{
"family": "Petrović",
"given": "Maja"
},
{
"family": "Lapčević",
"given": "Simona"
},
{
"family": "Matić",
"given": "Ivana Z"
},
{
"family": "Bojić",
"given": "Luka"
},
{
"family": "Nikitović",
"given": "Marina"
},
{
"family": "Stanojković",
"given": "Tatjana"
},
{
"family": "Stanisavljević Ninković",
"given": "Danijela"
}
],
"container-title-short":
"volume": "16",
"issue": "1",
"page": "25942",
"DOI": "10.1038/
"PMID": "42252325",
"PMCID": "PMC13486710",
"ISSN": "2045-2322",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
8
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/ijms27167240
- 1-Piperidine Propionic Acid Inhibits PAR2/
SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness. Journal: International journal of molecular sciencesIn common: other condition, cellular / molecular, 2 references - [2] doi:10.3390/genes17050511
- Machine Learning-Based Classification of Gliomas and Tumor Grades with SHAP-Guided Feature Interpretation.Journal: GenesIn common: other condition, cellular / molecular, 2 references
- [3] doi:10.1186/s40478-026-02312-z
- Dissecting acute neuronal responses to glioblastoma using a dual-interface human iPSC neuronal culture platform.Journal: Acta neuropathologica communicationsIn common: other condition, cellular / molecular, 1 reference
- [4] doi:10.1038/s41598-026-45845-y
- Identification of natural FGFR3 inhibitor for glioma using integrated computational and microRNA regulatory analysis.Journal: Scientific reportsIn common: other condition, cellular / molecular, 1 reference
- [5] doi:10.3389/fendo.2026.1819985
- Zinc oxide nanoparticles mitigate insulin resistance in a D-galactose-induced C57BL/
6 mouse model. Journal: Frontiers in endocrinologyIn common: other condition, cellular / molecular, 1 reference - [6] doi:10.1186/s40478-026-02228-8
- microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer's disease patients.Journal: Acta neuropathologica communicationsIn common: cellular / molecular, 1 reference
- [7] doi:10.1016/j.stemcr.2026.102927
- miR-151-5p regulates neural stem cell fate by targeting APH1A to modulate Notch signaling gradients.Journal: Stem cell reportsIn common: cellular / molecular, 1 reference
- [8] doi:10.3389/fonc.2026.1742452
- SLC10A3 drives glioblastoma progression by remodeling the immunosuppressive microenvironment and promoting M2 macrophage migration.Journal: Frontiers in oncologyIn common: other condition, 1 reference
- [9] doi:10.1177/11779322251411169 [code]
- Comprehensive ceRNA Profiling Uncovers Clinically Relevant Hub lncRNAs in Glioblastoma.Journal: Bioinformatics and biology insightsIn common: other condition, 1 reference
- [10] doi:10.1038/s41592-026-03057-2 [code]
- CREsted: modeling genomic and synthetic cell-type-specific enhancers across tissues and species.Journal: Nature methodsIn common: 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.